Literature DB >> 31699214

Thymocyte selection: From signaling to epigenetic regulation.

Jun Lyu1, Lie Wang1, Linrong Lu2.   

Abstract

During thymocyte development at the double positive stage, thymocytes are subjected to a TCR quality check process termed "thymocyte selection." TCRs with proper binding capabilities to MHC molecules (with self-peptide) are able to transduce cell survival signals and allow the continuing of development to single positive T cells. It has been known that TCRs in DP cells can transduce signals with higher efficiency than peripheral mature T cells, even though they share most of the signaling components. Recent studies have revealed some thymocyte-specific signaling modulators including Themis and Tespa1. The activation of TCR signaling during positive selection results in the activation of several key transcription factors and extensive gene expression change, which has been revealed by newly developed systemic transcriptome analysis tools, and could be used for the evaluation of positive selection process. The fate determination postpositive selection is also governed on the epigenetic level including both DNA methylation and histone modifications.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Positive selection; TCR signaling; Tespa1; Themis; Thymocyte

Mesh:

Substances:

Year:  2019        PMID: 31699214     DOI: 10.1016/bs.ai.2019.08.005

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  3 in total

Review 1.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

2.  Mobilizing ER IP3 receptors as a mechanism to enhance calcium signaling.

Authors:  Linrong Lu
Journal:  Cell Mol Immunol       Date:  2021-07-12       Impact factor: 22.096

Review 3.  New Insights into Epigenetic Regulation of T Cell Differentiation.

Authors:  Avik Dutta; Harini Venkataganesh; Paul E Love
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.